MiT/TFE PROTEINS MEDIATE METABOLIC REPROGRAMMING IN PANCREATIC CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 09期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：904 / 904
页数：1
相关论文
共 50 条
  • [41] Metabolic reprogramming in renal cancer: Events of a metabolic disease
    Chakraborty, Samik
    Balan, Murugabaskar
    Sabarwal, Akash
    Choueiri, Toni K.
    Pal, Soumitro
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [42] Editorial: Metabolic reprogramming and cancer progression
    Yin, Qinan
    Poudel, Nabin
    Liu, Ziyi
    TRANSLATIONAL ONCOLOGY, 2023, 28
  • [43] Lipid metabolic reprogramming in cancer cells
    Beloribi-Djefaflia, S.
    Vasseur, S.
    Guillaumond, F.
    ONCOGENESIS, 2016, 5 : e189 - e189
  • [44] TORquing metabolic reprogramming in cancer cells
    Pusapati, Raju
    Settleman, Jeff
    CELL CYCLE, 2016, 15 (18) : 2387 - 2388
  • [45] Metabolic Reprogramming, Questioning, and Implications for Cancer
    Jacquet, Pierre
    Stephanou, Angelique
    BIOLOGY-BASEL, 2021, 10 (02): : 1 - 7
  • [46] Reprogramming the cancer epigenome by "metabolic transduction"
    Byun, Jung S.
    Gardner, Kevin
    FASEB JOURNAL, 2012, 26
  • [47] The cancer metabolic reprogramming and immune response
    Xia, Longzheng
    Oyang, Linda
    Lin, Jinguan
    Tan, Shiming
    Han, Yaqian
    Wu, Nayiyuan
    Yi, Pin
    Tang, Lu
    Pan, Qing
    Rao, Shan
    Liang, Jiaxin
    Tang, Yanyan
    Su, Min
    Luo, Xia
    Yang, Yiqing
    Shi, Yingrui
    Wang, Hui
    Zhou, Yujuan
    Liao, Qianjin
    MOLECULAR CANCER, 2021, 20 (01)
  • [48] Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
    Sreedhar, Annapoorna
    Zhao, Yunfeng
    BIOMEDICAL REPORTS, 2018, 8 (01) : 3 - 10
  • [49] The role of metabolic reprogramming in kidney cancer
    Chen, Ziyi
    Zhang, Xiaohong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [50] Metabolic reprogramming and kidney cancer progression
    DeBerardinis, Ralph J.
    CANCER RESEARCH, 2023, 83 (16)
12345